Truist Securities Maintains Buy on Praxis Precision Medicine, Raises Price Target to $715
Praxis Precision Medicines Inc PRAX
$342.58
▼ -0.85%
($-2.94)
Open
$337.80
Prev Close
$345.52
Day Range
$334.00 – $350.45
52W Range
$35.21 – $358.76
Market Cap
$9.55B
Beta
2.80
EPS (TTM)
$-13.45
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-10-16 |
| Shares Out. | 27,850,000 |
| Website | praxismedicines.com/ ↗ |
| Phone | 16173008460 |
Praxis Precision Medicines Inc is a publicly traded company under the ticker symbol PRAX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
23 analysts (2026-05-01)
📰 Latest News for PRAX
Praxis Precision Medicines, Inc. (PRAX) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Transcript : Praxis Precision Medicines, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 04
Praxis Precision Medicines, Inc. (PRAX) Q1 2026 Earnings Call Transcript
Transcript : Praxis Precision Medicines, Inc., Q1 2026 Earnings Call, May 07, 2026
Wedbush Maintains Underperform on Praxis Precision Medicine, Raises Price Target to $166
BTIG Reiterates Buy on Praxis Precision Medicine, Maintains $843 Price Target
Praxis Precision Medicines (NASDAQ:PRAX) Beats Q1 Estimates as FDA Accepts Two Key Drug Applications